Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Shih Hsin Hsiao"'
Autor:
Shih‐Hsin Hsiao, Wan‐Ting Chen, Chi‐Li Chung, Yu‐Ting Chou, Sey‐En Lin, Shiao‐Ya Hong, Jer‐Hwa Chang, Tzu‐Hao Chang, Li‐Nien Chien
Publikováno v:
Cancer Medicine, Vol 11, Iss 10, Pp 2067-2078 (2022)
Abstract Background and Purpose Although cytotoxic platinum‐based adjuvant chemotherapy (pACT) has been recommended for patients with completely resected early‐stage (ES) non–small‐cell lung cancer (ES‐NSCLC), therapeutic regimens for NSCLC
Externí odkaz:
https://doaj.org/article/28d710f2b7614221858f539ac4e9e7ee
Autor:
Shih-Hsin Hsiao, Yuh-Mou Sue, Chih-Chin Kao, Hui-Wen Chang, Yen-Chung Lin, Ching-Sheng Hung, Yi-Chen Hsieh, Shiao-Ya Hong, Chi-Li Chung, Jer-Hwa Chang, Ying-Shih Su, Ming-Che Liu, Kevin Shu-Leung Lai, Ko-Ling Chien, Jude Chu-Chun Wang, Chung-Yi Cheng, Te-Chao Fang
Publikováno v:
Vaccines, Vol 11, Iss 7, p 1161 (2023)
Background: Hemodialysis patients are at an increased risk of SARS-CoV-2 infection and are excluded from preauthorization COVID-19 vaccine trials; therefore, their immunogenicity is uncertain. Methods: To compare the antibody responses to homologous
Externí odkaz:
https://doaj.org/article/8b2eb08ccf0d47cf8f3adb3f14a378ae
Autor:
Po-Lan Su, MD, Gee-Chen Chang, MD, Shih-Hsin Hsiao, MD, Te-Chun Hsia, MD, Meng-Chih Lin, MD, Min-Hsi Lin, MD, Jin-Yuan Shih, MD, Cheng-Ta Yang, MD, Sheng-Hsiung Yang, MD, Yuh-Min Chen, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 3, Pp 100292- (2022)
Introduction: Patients with stage III NSCLC represent a very heterogenous group that requires different treatment strategies, especially in patients with N2 (2 nearby lymph nodes having cancer)-positive NSCLC and unresectable EGFR-mutant NSCLC. This
Externí odkaz:
https://doaj.org/article/3a5c4624258c4db3a2d7889c77f12479
Autor:
Jer-Hwa Chang, Jeng-Fong Chiou, Ching-Sheng Hung, Ming-Che Liu, Hui-Wen Chang, Shiao-Ya Hong, Cheng-Yi Wang, Yi-Ling Lin, Yi-Chen Hsieh, Chi-Li Chung, Ying-Shih Su, Shu-Tai Shen Hsiao, Doresses Liu, Jian-Jong Liang, Chun-Che Liao, Chih-Shin Chang, Kevin Shu-Leung Lai, Han-Chuan Chuang, Ko-Ling Chien, Wei-Ciao Wu, Yuan-Chii G. Lee, Sey-En Lin, Yung-Kang Shen, Chiung-Fang Hsu, Jude Chu-Chun Wang, Shih-Hsin Hsiao
Publikováno v:
Vaccines, Vol 10, Iss 2, p 312 (2022)
Background: The ChAdOx1 nCoV-19 vaccine has been widely administered against SARS-CoV-2 infection; however, data regarding its immunogenicity, reactogenicity, and potential differences in responses among Asian populations remain scarce. Methods: 270
Externí odkaz:
https://doaj.org/article/3fc9e74a83354ee9a7c8d4dbdf0558b7
Autor:
Chung-Yi Cheng, Te-Chao Fang, Hung-Wei Liao, Tso-Hsiao Chen, Jer-Hwa Chang, Yen-Chung Lin, Chih-Chin Kao, Ming-Che Liu, Hui-Wen Chang, Ching-Sheng Hung, Jude Chu-Chun Wang, Shih-Hsin Hsiao, Yuh-Mou Sue
Publikováno v:
Vaccines, Vol 10, Iss 2, p 338 (2022)
Background: Chronic kidney disease (CKD) patients tend to have a reduced immune response to infection and vaccination. The efficacy of current available COVID-19 vaccines in CKD patients has not been widely evaluated. Methods: In the present study, t
Externí odkaz:
https://doaj.org/article/0e27c52df00540dfbe75a514f5406f1e
Publikováno v:
Biology, Vol 10, Iss 10, p 1023 (2021)
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently become a novel pandemic event following the swine flu that occurred in 2009, which was caused by the influenza A virus (H1N1 sub
Externí odkaz:
https://doaj.org/article/05f9128145db48f4b530e1d8c08cf3ec
Autor:
Fang, Shih-Hsin Hsiao, Yuh-Mou Sue, Chih-Chin Kao, Hui-Wen Chang, Yen-Chung Lin, Ching-Sheng Hung, Yi-Chen Hsieh, Shiao-Ya Hong, Chi-Li Chung, Jer-Hwa Chang, Ying-Shih Su, Ming-Che Liu, Kevin Shu-Leung Lai, Ko-Ling Chien, Jude Chu-Chun Wang, Chung-Yi Cheng, Te-Chao
Publikováno v:
Vaccines; Volume 11; Issue 7; Pages: 1161
Background: Hemodialysis patients are at an increased risk of SARS-CoV-2 infection and are excluded from preauthorization COVID-19 vaccine trials; therefore, their immunogenicity is uncertain. Methods: To compare the antibody responses to homologous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::4d2000eaf7fe8db44e87e273554827fb
Autor:
Hua‐Ching Chang, Yi‐Shuan Sheen, Po‐Huan Ko, Chien‐Jui Cheng, Chia‐Yu Chu, Shih‐Hsin Hsiao, Tsai‐Hsien Lee
Publikováno v:
JDDG: Journal der Deutschen Dermatologischen Gesellschaft.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::821a3dc431be108d1a95f3a63956664a
https://doi.org/10.1111/ddg.15067
https://doi.org/10.1111/ddg.15067
Publikováno v:
Pharmaceuticals, Vol 14, Iss 6, p 585 (2021)
Lipoteichoic acid (LTA) stimulates pleural mesothelial cell (PMC) to overproduce plasminogen activator inhibitor-1 (PAI-1), and thus may promote pleural fibrosis in Gram-positive bacteria (GPB) parapneumonic effusion (PPE). Histone deacetylase inhibi
Externí odkaz:
https://doaj.org/article/1c877b07864942b296bc3ac9c025b719
Autor:
Yu-Ting Chou, Sey-En Lin, Shih-Hsin Hsiao, Wen-Chien Huang, Junn-Liang Chang, Chia-Cherng Yu, An-Chun Lee, Kuan-Lin Lee, Ming-Han Kuo, Yu-Fan Chiu, Wen Hwang
Mutations in EGFR drive tumor growth but render tumor cells sensitive to treatment with EGFR tyrosine kinase inhibitors (TKI). Phenotypic alteration in epithelial-to-mesenchymal transition (EMT) has been linked to the TKI resistance in lung adenocarc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4dc00a828bbd26de58107bb1c26cac0e
https://doi.org/10.1158/0008-5472.c.6508854.v1
https://doi.org/10.1158/0008-5472.c.6508854.v1
